CRYSTAL OBERLE: Open Payments
NPI 1720416563 · DAKOTA DUNES, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 75 payments from 16 companies in 2025. Trend: 2023 $1,283 · 2024 $1,229 · 2025 $1,487
Food & beverage: $1,387Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $363 |
| GENZYME CORPORATION | 9 | $194 |
| Amgen Inc. | 14 | $186 |
| UCB, Inc. | 8 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| Lilly USA, LLC | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| LEO Pharma Inc. | 3 | $73 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
Products named: TREMFYA, DUPIXENT, OTEZLA, Bimzelx, TALTZ, COSENTYX, ADBRY, Zoryve.
Industry payments across SD — which companies pay providers there.
